S. Costantini

ORCID: 0000-0001-9404-5450 · 4 papers in corpus
meta-analysis 2022
Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.13737

BACKGROUND: Ovarian carcinoma (OC) is one of the most widespread tumors in the world and is characterized by low survival rates. OBJECTIVE: To determine whether the levonorgestrel-releasing intrauterine system (LNG-IUS) can prevent OC. SE…

review 2020
Borderline ovarian tumours: management in the era of fertility-sparing surgery
Ecancermedicalscience ·doi:10.3332/ecancer.2020.1031

Borderline ovarian tumours (BOTs) are ovarian neoplasms characterised by epithelial proliferation, variable nuclear atypia and no evidence of destructive stromal invasion. BOTs account for approximately 15% of all epithelial ovarian cancers…

other 2001
Transvaginal ultrasonography and hysterosonography to monitor endometrial effects in tamoxifen-treated patients
European journal of gynaecological oncology

PURPOSE OF INVESTIGATION: Our purpose was to evaluate if, during tamoxifen treatment, hysterosonography may increase diagnostic accuracy when compared with transvaginal ultrasonography and to identify, when and in how many cases, further bi…

nonrandomized-trial 1990
Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results
Fertility and sterility ·doi:10.1016/s0015-0282(16)53999-5

Thirty-two patients with laparoscopic diagnosis of endometriosis were treated for 6 months with the gonadotropin-releasing hormone agonist goserelin depot. Hormonal and clinical evaluations were conducted during treatment and for a 6-month …